Douglass Winthrop Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$473K Hold
1,214
0.01% 229
2026
Q1
$575K Hold
1,214
0.01% 203
2025
Q4
$567K Buy
1,214
+562
+86% +$261K 0.01% 205
2025
Q3
$278K Buy
+652
New +$253K ﹤0.01% 273
2020
Q2
Sell
-10,000
Closed -$898K 240
2020
Q1
$898K Sell
10,000
-10,000
-50% -$1.29M 0.04% 106
2019
Q4
$2.96M Sell
20,000
-2,600
-12% -$349K 0.1% 77
2019
Q3
$2.72M Sell
22,600
-2,000
-8% -$258K 0.1% 78
2019
Q2
$3.33M Hold
24,600
0.13% 73
2019
Q1
$3.21M Hold
24,600
0.14% 75
2018
Q4
$3.06M Buy
+24,600
New +$3.3M 0.15% 78

Other funds holding HCA

Douglass Winthrop Advisors's HCA Position: Q2 2026 in Review

Douglass Winthrop Advisors held its HCA Healthcare (HCA) position steady in Q2 2026 at 1,214 shares worth $473K. The position accounts for 0.01% of the portfolio, ranked #229.

Douglass Winthrop Advisors first reported a position in HCA in Q4 2018 and has held it in 10 quarters since. The position peaked at $3.33M in Q2 2019. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Douglass Winthrop Advisors held 1,214 shares of HCA Healthcare worth $473K as of Q2 2026.
  • Douglass Winthrop Advisors left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.01% of Douglass Winthrop Advisors's portfolio in Q2 2026, its #229 holding.
  • Douglass Winthrop Advisors first reported a position in HCA Healthcare in Q4 2018 and has held it in 10 quarters since.
  • Douglass Winthrop Advisors's HCA Healthcare position peaked at $3.33M in Q2 2019.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.